U.S. Markets closed

Why This Analyst Sees Care.com Fetching Up To $16/Share In Potential Sale

Jayson Derrick

Care.com Inc (NYSE: CRCM), an online platform to help people find and manage family care, is reportedly undertaking a strategic review and could sell itself in the $14 to $16 per share range, according to BTIG.

The Analyst

BTIG analyst Marvin Fong maintains a Buy rating on Care's stock with a $13 price target.

The Thesis

Care.com appears to be "ripe for a possible sale" of itself given multiple vacant positions in senior management along with frustrated shareholders and pressure from activist investor Engine Capital, Fong wrote in a note.

On the other hand, the company does have a leading platform within an attractive market with a short list of potential buyers, including IAC/InterActiveCorp (NASDAQ: IAC), Internet Brands, or a private equity group.

Fong said a potential buyer would appreciate Care's more enhanced background checks and management's strategy to fight back against recent negative press. The company also boasts a "sound" balance sheet and positive free cash flow.

At this point a sale is "more likely than not" to take place and a price tag of $14 to $16 implies a multiple of 22 to 26 times 2020 estimated Adjusted EBITDA.

Price Action

Shares of Care.com were trading higher by 8.4% Monday at $12.13.

Latest Ratings for CRCM

Date Firm Action From To
Aug 2019 Upgrades Neutral Buy
Jun 2019 Downgrades Buy Hold
Apr 2019 Downgrades Buy Neutral

View More Analyst Ratings for CRCM
View the Latest Analyst Ratings

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.